Practice Guideline
doi: 10.1111/j.1440-1746.2007.04883.x.
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection
Affiliations
- PMID: 17444847
- DOI: 10.1111/j.1440-1746.2007.04883.x
Item in Clipboard
Practice Guideline
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection
J Gastroenterol Hepatol.
2007 May.
No abstract available
Comment in
-
New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.J Gastroenterol Hepatol. 2007 May;22(5):607-10. doi: 10.1111/j.1440-1746.2007.04969.x. J Gastroenterol Hepatol. 2007. PMID: 17444844 No abstract available.
Similar articles
-
New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.J Gastroenterol Hepatol. 2007 May;22(5):607-10. doi: 10.1111/j.1440-1746.2007.04969.x. J Gastroenterol Hepatol. 2007. PMID: 17444844 No abstract available.
-
HIV and hepatitis C coinfection.J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. J Gastroenterol Hepatol. 2008. PMID: 18707597 Review.
-
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735. Liver Transpl. 2009. PMID: 19718643
-
Hepatitis C virus infection.N Engl J Med. 2001 Jul 5;345(1):41-52. doi: 10.1056/NEJM200107053450107. N Engl J Med. 2001. PMID: 11439948 Review. No abstract available.
-
Diagnosis, evaluation, and treatment of HIV/HCV coinfection.Am Clin Lab. 2001 Oct-Nov;20(9):26-32. Am Clin Lab. 2001. PMID: 11766416 Review. No abstract available.
Cited by
-
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.Proc Natl Acad Sci U S A. 2013 May 7;110(19):7844-9. doi: 10.1073/pnas.1306138110. Epub 2013 Apr 23. Proc Natl Acad Sci U S A. 2013. PMID: 23613588 Free PMC article.
-
APASL consensus statements and recommendation on treatment of hepatitis C.Hepatol Int. 2016 Sep;10(5):702-26. doi: 10.1007/s12072-016-9717-6. Epub 2016 Apr 29. Hepatol Int. 2016. PMID: 27130427 Free PMC article. Review.
-
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy.Oncotarget. 2016 Sep 20;7(38):61325-61335. doi: 10.18632/oncotarget.11348. Oncotarget. 2016. PMID: 27542257 Free PMC article.
-
Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.Pharmgenomics Pers Med. 2010;3:1-13. doi: 10.2147/pgpm.s4461. Epub 2010 Mar 11. Pharmgenomics Pers Med. 2010. PMID: 23226039 Free PMC article.
-
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.Med Microbiol Immunol. 2010 Feb;199(1):1-10. doi: 10.1007/s00430-009-0131-8. Epub 2009 Nov 10. Med Microbiol Immunol. 2010. PMID: 19902246 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
